Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned

Survival of glioblastoma multiforme (GBM) with the current recommended treatment is poor. Reported median survivals are approximately 8–15 months. Based on recent publications from animal models, combining cancer drugs, radiation, and diet-metabolic treatments may be a new route to better survivals....

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Kenneth A., Noel, Mary, Nikolai, Michele, Chang, Howard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834833/
https://www.ncbi.nlm.nih.gov/pubmed/29536011
http://dx.doi.org/10.3389/fnut.2018.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834833/
https://www.ncbi.nlm.nih.gov/pubmed/29536011
http://dx.doi.org/10.3389/fnut.2018.00011

Ejemplares similares